FDA is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years 2028 through 2032. The public meeting will be held on December 3, 2025, from 9 a.m. to 12 p.m ET.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ghWctQU
No comments:
Post a Comment